St. Johns Investment Management Company LLC Lowers Holdings in Procter & Gamble Company (The) $PG

St. Johns Investment Management Company LLC trimmed its holdings in Procter & Gamble Company (The) (NYSE:PGFree Report) by 10.6% in the 2nd quarter, HoldingsChannel reports. The fund owned 6,203 shares of the company’s stock after selling 736 shares during the quarter. St. Johns Investment Management Company LLC’s holdings in Procter & Gamble were worth $988,000 at the end of the most recent quarter.

Other hedge funds also recently added to or reduced their stakes in the company. MOKAN Wealth Management Inc. boosted its position in shares of Procter & Gamble by 13.7% during the second quarter. MOKAN Wealth Management Inc. now owns 15,319 shares of the company’s stock worth $2,442,000 after buying an additional 1,846 shares during the period. Benjamin Edwards Inc. boosted its position in shares of Procter & Gamble by 120.7% during the first quarter. Benjamin Edwards Inc. now owns 364,378 shares of the company’s stock worth $62,098,000 after buying an additional 199,258 shares during the period. Capital Investment Advisory Services LLC boosted its position in shares of Procter & Gamble by 13.8% during the first quarter. Capital Investment Advisory Services LLC now owns 37,709 shares of the company’s stock worth $6,426,000 after buying an additional 4,562 shares during the period. World Investment Advisors boosted its position in shares of Procter & Gamble by 6.0% during the first quarter. World Investment Advisors now owns 50,913 shares of the company’s stock worth $8,677,000 after buying an additional 2,886 shares during the period. Finally, Concurrent Investment Advisors LLC boosted its holdings in Procter & Gamble by 26.4% in the first quarter. Concurrent Investment Advisors LLC now owns 120,002 shares of the company’s stock valued at $20,451,000 after purchasing an additional 25,059 shares during the period. 65.77% of the stock is currently owned by hedge funds and other institutional investors.

Procter & Gamble Stock Down 0.2%

Procter & Gamble stock opened at $151.61 on Wednesday. Procter & Gamble Company has a 1-year low of $146.96 and a 1-year high of $180.43. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.70 and a quick ratio of 0.49. The stock has a market cap of $354.84 billion, a PE ratio of 23.29, a P/E/G ratio of 4.03 and a beta of 0.36. The stock’s fifty day moving average is $154.79 and its two-hundred day moving average is $158.54.

Procter & Gamble (NYSE:PGGet Free Report) last posted its quarterly earnings results on Tuesday, July 29th. The company reported $1.48 earnings per share for the quarter, beating analysts’ consensus estimates of $1.42 by $0.06. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.The company had revenue of $20.89 billion for the quarter, compared to analysts’ expectations of $20.79 billion. During the same period last year, the firm earned $1.40 earnings per share. Procter & Gamble’s quarterly revenue was up 1.7% on a year-over-year basis. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. On average, sell-side analysts expect that Procter & Gamble Company will post 6.91 EPS for the current fiscal year.

Procter & Gamble Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, November 17th. Stockholders of record on Friday, October 24th will be issued a $1.0568 dividend. This represents a $4.23 annualized dividend and a dividend yield of 2.8%. The ex-dividend date of this dividend is Friday, October 24th. Procter & Gamble’s payout ratio is presently 64.98%.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on PG shares. Barclays decreased their target price on Procter & Gamble from $164.00 to $153.00 and set an “equal weight” rating for the company in a report on Wednesday, October 1st. Raymond James Financial decreased their target price on Procter & Gamble from $185.00 to $175.00 and set an “outperform” rating for the company in a report on Monday. BNP Paribas reiterated an “outperform” rating and issued a $177.00 target price on shares of Procter & Gamble in a report on Friday, August 15th. BNP Paribas Exane decreased their target price on Procter & Gamble from $177.00 to $172.00 and set an “outperform” rating for the company in a report on Tuesday, September 23rd. Finally, UBS Group decreased their target price on Procter & Gamble from $180.00 to $176.00 and set a “buy” rating for the company in a report on Wednesday, October 8th. Eleven investment analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $171.68.

Read Our Latest Research Report on Procter & Gamble

Insiders Place Their Bets

In other news, CEO Jon R. Moeller sold 11,684 shares of the business’s stock in a transaction dated Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total value of $1,778,655.32. Following the completion of the sale, the chief executive officer directly owned 319,932 shares of the company’s stock, valued at approximately $48,703,248.36. The trade was a 3.52% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Andre Schulten sold 4,252 shares of the business’s stock in a transaction dated Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total value of $647,281.96. Following the completion of the sale, the chief financial officer directly owned 53,992 shares of the company’s stock, valued at $8,219,202.16. The trade was a 7.30% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 149,763 shares of company stock worth $23,421,279. Corporate insiders own 0.20% of the company’s stock.

Procter & Gamble Company Profile

(Free Report)

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

Read More

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.